Bank of America Corp DE Acquires Shares of 3,138,786 Becton, Dickinson and Company $BDX

Key Points

• Bank of America acquired 3.14 million Becton, Dickinson and Company shares in the second quarter, valued at approximately $475 million and representing about 1.14% of the company.
• BDX reported quarterly EPS of $3.23 and revenue of $4.98 billion, exceeding analyst estimates, while revenue increased 5.4% year over year. Shares recently traded at $185.78, near their 52-week high.
• Analysts hold a consensus “Hold” rating with an average price target of $187.67. The company declared a quarterly dividend of $1.05, equivalent to a 2.3% annualized yield.

Bank of America Corp DE bought a new stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 3,138,786 shares of the medical instruments supplier's stock, valued at approximately $474,993,000. Bank of America Corp DE owned approximately 1.14% of Becton, Dickinson and Company as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the stock. Strategic Global Advisors LLC bought a new position in shares of Becton, Dickinson and Company in the 2nd quarter worth $4,620,000. Man Group plc boosted its position in Becton, Dickinson and Company by 30.9% during the 2nd quarter. Man Group plc now owns 18,549 shares of the medical instruments supplier's stock valued at $2,807,000 after buying an additional 4,384 shares during the period. First Bancorp Inc ME bought a new stake in shares of Becton, Dickinson and Company in the second quarter worth about $104,000. Roberts Glore & Co. Inc. IL grew its position in shares of Becton, Dickinson and Company by 1.0% in the 2nd quarter. Roberts Glore & Co. Inc. IL now owns 8,414 shares of the medical instruments supplier's stock worth $1,273,000 after buying an additional 85 shares during the last quarter. Finally, Jupiter Topco LLC purchased a new position in Becton, Dickinson and Company during the 2nd quarter valued at $75,944,000. Hedge funds and other institutional investors own 86.97% of the company's stock.

Insider Activity

In other Becton, Dickinson and Company news, EVP Roland Goette sold 2,438 shares of the business's stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $180.84, for a total transaction of $440,887.92. Following the sale, the executive vice president owned 14,856 shares in the company, valued at approximately $2,686,559.04. The trade was a 14.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Feld sold 165 shares of the stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $188.49, for a total transaction of $31,100.85. Following the completion of the sale, the executive vice president owned 19,720 shares in the company, valued at $3,717,022.80. The trade was a 0.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 8,005 shares of company stock worth $1,423,580. 0.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

BDX has been the subject of a number of research reports. The Goldman Sachs Group lowered their price objective on Becton, Dickinson and Company from $156.00 to $150.00 and set a "neutral" rating for the company in a research report on Wednesday, May 27th. Royal Bank Of Canada lifted their target price on Becton, Dickinson and Company from $180.00 to $190.00 and gave the stock a "sector perform" rating in a report on Thursday, August 13th. Bank of America boosted their price objective on shares of Becton, Dickinson and Company from $185.00 to $200.00 and gave the company a "neutral" rating in a report on Monday, August 31st. Stifel Nicolaus set a $195.00 target price on Becton, Dickinson and Company in a research report on Friday, August 7th. Finally, Jefferies Financial Group reissued a "buy" rating and set a $210.00 price objective on shares of Becton, Dickinson and Company in a research report on Thursday, August 6th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $187.67.

Becton, Dickinson and Company Trading Up 1.6%

Shares of NYSE BDX opened at $185.78 on Wednesday. The business's 50 day moving average is $173.65 and its two-hundred day moving average is $160.52. Becton, Dickinson and Company has a 1-year low of $127.59 and a 1-year high of $193.07. The stock has a market capitalization of $51.19 billion, a P/E ratio of 55.96, a PEG ratio of 12.89 and a beta of 0.21. The company has a debt-to-equity ratio of 0.55, a current ratio of 0.87 and a quick ratio of 0.51.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $3.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.14 by $0.09. The business had revenue of $4.98 billion during the quarter, compared to the consensus estimate of $4.89 billion. Becton, Dickinson and Company had a net margin of 4.52% and a return on equity of 14.79%. The firm's quarterly revenue was up 5.4% compared to the same quarter last year. During the same quarter last year, the firm earned $3.68 earnings per share. Becton, Dickinson and Company has set its FY 2026 guidance at 12.620-12.720 EPS. As a group, research analysts expect that Becton, Dickinson and Company will post 12.67 EPS for the current year.

Becton, Dickinson and Company Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 9th will be issued a $1.05 dividend. The ex-dividend date is Wednesday, September 9th. This represents a $4.20 dividend on an annualized basis and a yield of 2.3%. Becton, Dickinson and Company's payout ratio is currently 126.51%.

About Becton, Dickinson and Company

Becton, Dickinson and Company, commonly known as BD, is a global medical technology company that develops, manufactures and sells products used by healthcare providers, researchers and pharmaceutical companies. Founded in 1897 by Maxwell Becton and Fairleigh Dickinson, the company is headquartered in Franklin Lakes, New Jersey.

BD's products support medication delivery, infection prevention, diagnostics and surgical care. Its portfolio includes needles, syringes, injection devices, infusion products, medication-management systems, specimen-collection products, laboratory instruments and diagnostic technologies.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.